CN110801492A

CN110801492A - Traditional Chinese medicine formula for treating aplastic anemia

Info

Publication number: CN110801492A
Application number: CN201811424171.1A
Authority: CN
Inventors: 谢志仁
Original assignee: Individual
Current assignee: Individual
Priority date: 2018-11-27
Filing date: 2018-11-27
Publication date: 2020-02-18

Abstract

The invention has the following patents: can cure aplastic anemia, and the price of the traditional Chinese medicine can be accepted by families of common patients. The invention has the following patents: the hereditary secret formula is invented by using the study of students, comprehension and medical experience in a lifetime after being handed down from ancestors, and the hereditary secret formula is left. The invention has the technical characteristics that: 30g of hairyvein agrimony, 30g of donkey-hide gelatin, 20g of cuttle bone, 30g of beautyberry and 5g of bletilla striata. Is prepared from five Chinese-medicinal materials. The invention has the following patents: can restore and enhance the hematopoietic function of human body. The application method of the invention comprises the following steps: decocting with water or making into powder, and making into honeyed pill; or making into powder, capsule, and honeyed pill.

Description

Traditional Chinese medicine formula for treating aplastic anemia

The invention aims to save patients and also help the family happy and benefit the society.

The technical background aplastic anemia causes a great number of families to fall into the profound difficulty and take away a great number of lives. To date, no better cure is available.

Therefore, a medicine and a method which have the price acceptable by domestic patients and can cure the aplastic anemia are urgently to be made.

In order to solve the problems, the invention discloses a traditional Chinese medicine formula capable of curing aplastic anemia.

The method comprises the following steps: the species, dosage and application method of Chinese herbal medicine.

The invention relates to a Chinese medicine prescription handed down from ancestors. The Chinese patent medicine is developed by graduate schools, wisdom and experience to cure the grandfather and grandfather, the aplastic anemia of the grandfather and the grandfather is thoroughly cured, and then the prescription is passed on.

The invention aims to restore and enhance the hematopoietic capacity of human bodies and can cure aplastic anemia and common anemia.

Has the advantages that: can cure the aplastic anemia, has the price which can be borne by all patients, and also has happy smiling face for the patients, which benefits families and society.

The prescription and the curing mechanism show that:

aplastic anemia, i.e., impaired hematopoietic function of the bone marrow, either non-hematopoietic or weak hematopoietic capacity, fails to meet the needs of blood metabolism. The main characteristics are that the platelet is too low, the bleeding is caused by slight exogenous factors, the internal bleeding also occurs without exogenous factors, the self does not produce blood or produces less blood, the blood needed by the body metabolism can not be supplemented, and the life can be maintained only by blood transfusion. The causes of the disease are as follows: the healthy qi is not strong but the origin is not fixed, and the body is damaged due to invasion of exogenous pathogenic factors. This healthy qi strengthens the excess, and pathogenic factors do not invade.

Therefore, in treating the disease, bleeding is controlled, namely the hemostasis is performed, meanwhile, the toxin and the pathological cells which cause pathological changes in the body are removed by detoxification, the activity of hematopoietic organs is restored and enhanced, the growth, development and propagation of normal hematopoietic cells are promoted, and the strengthening of the body resistance, the consolidation of the foundation and the immunization are performed again.

The liver is mainly used for metabolism, is a blood bank, is an important organ for biotransformation and detoxification of human bodies, and is required to treat liver, recover liver activity and enhance detoxification and detoxification functions to expel exogenous pathogenic factors (mainly remove various toxins in the bodies); meanwhile, kidneys dominate the innate root, while strong kidneys consolidate the root and prevent exogenous pathogenic factors from entering. Patients with aplastic anemia are usually accompanied by liver and kidney diseases. Therefore, the key point is to treat liver and kidney simultaneously.

Therefore, the invention takes the mechanisms of astringency and hemostasis, eliminating exogenous pathogenic factors, repairing organs, strengthening body resistance and consolidating constitution, and building immunity to recover the generating, breeding and cultivating capability of hematopoietic cells, thereby recovering bone marrow, enhancing the hematopoietic capability and curing aplastic anemia.

The prescription is mainly technically characterized in that: 30g of donkey-hide gelatin, 30g of hairyvein agrimony, 20g of cuttle bone, 30g of beautyberry and 5g of bletilla striata. The method comprises the following steps:

agrimony: astringe to stop bleeding, remove toxicity and tonify deficiency. The inhibition rate of the extract on cancer cells is 100 percent, and the extract has 100 percent of growth promotion effect on normal human cells (see Baidu encyclopedia)

Cuttlefish bone: astringe to stop bleeding, secure essence and stop leucorrhea. It can enter liver and kidney blood system, and has effects of promoting blood circulation, activating channels and collaterals, nourishing liver blood, dispelling cold and dampness, stopping bleeding, stopping leukorrhagia, stopping nocturnal emission, and relieving hyperacidity.

And (3) purple beautyberry: cool blood, astringe to stop bleeding, clear heat and remove toxicity, increase blood platelets.

E, donkey-hide gelatin: enrich blood, stop bleeding, nourish yin to moisten dryness. "tonifying blood and liquid". The colla Corii Asini can directly act on hematopoietic chain to increase hematopoietic cells, leukocytes, erythrocytes and hemoglobin of bone marrow, promote hematopoietic function of bone marrow, rapidly recover erythrocytes in hemorrhagic anemia, and enhance immunity.

Bletilla striata: astringe to stop bleeding, resolve swelling and promote tissue regeneration. It also has lung tonifying effect.

The five medicines in the prescription perfectly realize the combination of curing the aplastic anemia.

The using method comprises the following steps: decocted in water or made into honeyed pill for oral administration. It can be made into powder, capsule, and honeyed pill.

The invention can cure aplastic anemia and has good treatment effect on non-aplastic anemia

The drawings are not described.

Claims

1. A traditional Chinese medicine formula capable of radically and thoroughly treating aplastic anemia and anemia is characterized in that: can be decocted in water for oral administration; can be made into powder, honeyed pill or capsule for oral administration with warm boiled water; or processing to make into honeyed pill, capsule, or powder.

2. The traditional Chinese medicine formula of claim 1, which is characterized in that:

30g of donkey-hide gelatin, 30g of hairyvein agrimony, 20g of cuttle bone, 30g of beautyberry and 5g of bletilla striata.